SB 1060 — Neurofibromatosis Research Grants
Last action — Died in Health Policy
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced January 05, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
Summary
Neurofibromatosis Research Grants; Creating the Neurofibromatosis Disease Grant Program within the Department of Health; providing the purpose of the program; allowing certain grant proposals to receive preference in the awarding of grants; requiring the department to award grants after consulting with the Rare Disease Advisory Council; prohibiting members of the council or peer review panels from participating in discussions or decisions if there are certain conflicts of interest, etc.
Bill Text
- Introduced S 1060 Filed Current pdf
Action History
-
Died in Health Policy
-
Introduced
-
Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
-
Filed
Sponsors
- Ana Maria Rodriguez · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 163 not signed on
Sponsors (1)
- Rodriguez, Ana Maria Republican
Co-sponsors (0)
None.
Not signed on (163)
163 members have not signed on to this bill.
Show all 163 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 1060 do?
- Neurofibromatosis Research Grants; Creating the Neurofibromatosis Disease Grant Program within the Department of Health; providing the purpose of the program; allowing certain grant proposals to receive preference in the awarding of grants; requiring the department to award grants after consulting with the Rare Disease Advisory Council; prohibiting members of the council or peer review panels from participating in discussions or decisions if there are certain conflicts of interest, etc.
- Who sponsors SB 1060?
- SB 1060 is sponsored by Rodriguez, Ana Maria (Republican).
- What is the current status of SB 1060?
- This bill has been introduced in the Senate. Introduced January 05, 2026. It must pass committee before a floor vote.
- Where can I track SB 1060?
- Track SB 1060 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 1060
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 1060
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →